Apconix Careers Archive

ApconiX Welcomes Dr Craig Thomas

ApconiX Welcomes Dr Craig Thomas ApconiX is delighted to welcome Dr Craig Thomas who joins the team of nonclinical safety experts and will be working with Dr Richard Knight.  Craig has thirty-four years of drug discovery and management experience in the pharmaceutical industry.  Working in both drug discovery, regulatory [...]

By |2022-11-22T12:59:30+00:00October 15th, 2022|Company News, Toxicology, Careers|Comments Off on ApconiX Welcomes Dr Craig Thomas

ApconiX Welcomes Dr Amy Shepherd

ApconiX Welcomes Dr Amy Shepherd ApconiX is delighted to welcome Dr Amy Shepherd who joins the team of nonclinical safety experts and will be working with Dr Richard Knight. Amy is an experienced immunologist having worked for over 10 years in nonclinical and clinical safety program design with both [...]

By |2022-11-22T13:01:59+00:00October 8th, 2022|Company News, Toxicology, Careers|Comments Off on ApconiX Welcomes Dr Amy Shepherd

ApconiX Welcomes Scott Hackford

ApconiX Welcomes Scott Hackford ApconiX is delighted to welcome Scott Hackford who joins the team of nonclinical safety experts and will be working with Dr Richard Knight. Scott has over 12 years’ experience in a contract research organisation as a study director and lead toxicologist designing, conducting, and reporting [...]

By |2022-11-22T13:06:52+00:00October 1st, 2022|Company News, Toxicology, Careers|Comments Off on ApconiX Welcomes Scott Hackford

ApconiX Welcomes Bethan Kelly

ApconiX Welcomes Bethan Kelly ApconiX is delighted to welcome Bethan Kelly who joins for a years’ placement having just completed her second year of a bachelor’s degree in biology.  Bethan becomes part of the ion channel laboratory team and will be working with Dr Michael Morton. Studying Biology Bethan [...]

By |2022-11-22T13:17:02+00:00September 30th, 2022|Ion Channels, Company News, Careers|Comments Off on ApconiX Welcomes Bethan Kelly

ApconiX Welcomes Dr Kerry Illston

ApconiX Welcomes Dr Kerry Illston ApconiX is delighted to welcome Dr Kerry Illston who joins the team of nonclinical safety experts and will be working with Dr Richard Knight. Kerry is an experienced Project Manager with over 25 years’ experience in molecular toxicology, new target identification/validation and nonclinical safety [...]

By |2022-11-22T13:09:36+00:00September 23rd, 2022|Company News, Toxicology, Careers|Comments Off on ApconiX Welcomes Dr Kerry Illston

ApconiX Welcomes Michelle Blissett

ApconiX Welcomes Michelle Blissett ApconiX is delighted to welcome Michelle Blissett who joins the Acuity Target Safety Assessment team working with Professor Ruth Roberts and Dr James Sidaway.  With almost 20 years devoted to preclinical toxicology, Michelle has developed an excellent ability to conduct extensive literature searches, interrogating, analysing [...]

By |2022-11-08T14:36:42+00:00September 15th, 2022|Company News, Target Safety Assessments, Careers|Comments Off on ApconiX Welcomes Michelle Blissett

ApconiX Welcomes William Humfrey

ApconiX Welcomes William Humfrey ApconiX is delighted to welcome William Humfrey who joins the Acuity Target Safety Assessment team working with Professor Ruth Roberts and Dr James Sidaway.  Will studied for an integrated master’s degree in biomedical science at the University of Sheffield where he gained understanding of human [...]

By |2023-02-23T11:10:09+00:00September 8th, 2022|Company News, Target Safety Assessments, Careers|Comments Off on ApconiX Welcomes William Humfrey

ApconiX Welcomes Henry Bushell

ApconiX is Delighted to Welcome Henry Bushell ApconiX is delighted to welcome Henry Bushell who joins the Business Development team and is working with Dr Laurence Bishop.  Henry has a keen interest in economics and decided to acquire some business experience, joining ApconiX straight from sixth form college. Taking [...]

By |2023-09-28T15:23:42+01:00August 8th, 2022|Company News, Careers|Comments Off on ApconiX Welcomes Henry Bushell

Unravelling Some Mechanistic and Clinical Aspects of Immunological Drug-Drug Interactions

Unravelling Some Mechanistic and Clinical Aspects of Immunological Drug-Drug Interactions Dr Sean Hammond, as a member of an interdisciplinary team, has recently published the third of a series of papers seeking to unravel mechanistic and clinical aspects of the immunological drug-drug interactions that occur with immune checkpoint inhibitors. Immunotoxicology [...]

By |2022-09-21T12:23:33+01:00June 6th, 2022|Company News, Target Safety Assessments, Careers|Comments Off on Unravelling Some Mechanistic and Clinical Aspects of Immunological Drug-Drug Interactions

ApconiX Is Recruiting a Target Safety Biologist

ApconiX Is Recruiting a Target Safety Biologist The closing date for this job vacancy has passed.  Please visit our Come and Join Us page for current vacancies.  If you believe you have the skills and experience and would like to become part of our team please send your speculative CV to careers@apconix.com ApconiX [...]

By |2022-12-13T17:13:24+00:00May 31st, 2022|Company News, Target Safety Assessments, Careers|Comments Off on ApconiX Is Recruiting a Target Safety Biologist
Go to Top